OBJECTIVES: This study sought to compare the cost-effectiveness of a school-based hepatitis B vaccine delivery program with that of a vaccine delivery program associated with a network health maintenance organization (HMO). METHODS: The vaccination program enrolled 3359 sixth-grade students from 18 middle schools in Denver, Colo. Immunization status and direct and indirect program costs were compiled. The sensitivity of the outcomes was assessed by simulation methods. RESULTS: The per-dose cost-effectiveness ratio for the school-based delivery system was $31. This cost-effectiveness ratio remained stable when the model was simulated with costs that were underestimated or overestimated by 20%. In the network HMO, the direct cost per dose was $68 and the societal cost was $118 when the child's father worked full-time and the mother worked part-time. There is less than a 5% chance that the network HMO-based vaccination program could be more cost-effective than the school-based program. CONCLUSIONS: The cost per dose of the school-based program was significantly less than that of the network HMO-based program, because in the school program government-purchased vaccine was available at a lower cost and parents did not incur work-loss costs.
OBJECTIVES: This study sought to compare the cost-effectiveness of a school-based hepatitis B vaccine delivery program with that of a vaccine delivery program associated with a network health maintenance organization (HMO). METHODS: The vaccination program enrolled 3359 sixth-grade students from 18 middle schools in Denver, Colo. Immunization status and direct and indirect program costs were compiled. The sensitivity of the outcomes was assessed by simulation methods. RESULTS: The per-dose cost-effectiveness ratio for the school-based delivery system was $31. This cost-effectiveness ratio remained stable when the model was simulated with costs that were underestimated or overestimated by 20%. In the network HMO, the direct cost per dose was $68 and the societal cost was $118 when the child's father worked full-time and the mother worked part-time. There is less than a 5% chance that the network HMO-based vaccination program could be more cost-effective than the school-based program. CONCLUSIONS: The cost per dose of the school-based program was significantly less than that of the network HMO-based program, because in the school program government-purchased vaccine was available at a lower cost and parents did not incur work-loss costs.
Authors: M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer Journal: JAMA Date: 1990-03-02 Impact factor: 56.272
Authors: Maryse Guay; Anne-Marie Clouâtre; Manon Blackburn; Geneviève Baron; Philippe De Wals; Chantale Roy; Jean Desrochers; François Milord Journal: Can J Public Health Date: 2003 Jan-Feb
Authors: Francisco Averhoff; Leslie Linton; K Michael Peddecord; Christine Edwards; Wendy Wang; Daniel Fishbein Journal: Am J Public Health Date: 2004-06 Impact factor: 9.308
Authors: Jessica A Kadis; Annie-Laurie McRee; Sami L Gottlieb; Morgan R Lee; Paul L Reiter; Patricia J Dittus; Noel T Brewer Journal: Vaccine Date: 2011-02-05 Impact factor: 3.641
Authors: Steven G Federico; Lisa Abrams; Rachel M Everhart; Paul Melinkovich; Simon J Hambidge Journal: Am J Public Health Date: 2010-07-15 Impact factor: 9.308
Authors: Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jennifer Murphy Morgan; Adesola A Pitan; John M Clymer Journal: Am J Prev Med Date: 2016-02-01 Impact factor: 5.043
Authors: Peng-Jun Lu; David Yankey; Benjamin Fredua; Mei-Chuan Hung; Tanja Y Walker; Lauri E Markowitz; Laurie D Elam-Evans Journal: J Adolesc Health Date: 2021-04-16 Impact factor: 7.830